Insiders · PDSB

PDSB insider transactions

PDS Biotechnology Corporation (PDSB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PDSB

• 97d
  SEC Form 4 filed by Director Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by President/CEO Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Chief Financial Officer Boesgaard Lars

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Chief Scientific Officer Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Chief Operating Officer Toutain Stephan

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Chief Medical Officer Shepard Kirk V.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Senior VP, General Counsel Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Director Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Director Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 97d
  SEC Form 4 filed by Director Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 318d
  SEC Form 4 filed by Chief Financial Officer Boesgaard Lars

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 318d
  SEC Form 4 filed by Chief Scientific Officer Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 318d
  SEC Form 4 filed by Chief Operations Officer Toutain Stephan

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 318d
  SEC Form 4 filed by President/CEO Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 318d
  SEC Form 4 filed by Chief Medical Officer Shepard Kirk V.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 318d
  SEC Form 4 filed by Senior VP, General Counsel Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 362d
  SEC Form 4 filed by Director Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 362d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 362d
  SEC Form 4 filed by Director Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 362d
  SEC Form 4 filed by Director Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 362d
  SEC Form 4 filed by Director Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 462d
  Director Freitag Gregory Gene bought $25,000 worth of shares (15,060 units at $1.66), increasing direct ownership by 33% to 61,213 units (SEC Form 4)

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 462d
  Director Glover Stephen C. bought $25,001 worth of shares (15,061 units at $1.66), increasing direct ownership by 24% to 78,851 units (SEC Form 4)

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 713d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 713d
  SEC Form 4 filed by Director Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 713d
  SEC Form 4 filed by Director Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 713d
  SEC Form 4 filed by Director Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 713d
  SEC Form 4 filed by Director Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 713d
  SEC Form 4 filed by Director Sykes Richard

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 767d
  SEC Form 4 filed by Toutain Stephan

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 767d
  SEC Form 3 filed by new insider Toutain Stephan

  3 - PDS Biotechnology Corp (0001472091) (Issuer)
• 867d
  SEC Form 4 filed by Shepard Kirk V.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 867d
  SEC Form 3 filed by new insider Shepard Kirk V.

  3 - PDS Biotechnology Corp (0001472091) (Issuer)
• 917d
  SEC Form 4 filed by Boesgaard Lars

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 917d
  SEC Form 3 filed by new insider Boesgaard Lars

  3 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1057d
  SEC Form 4 filed by Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1057d
  SEC Form 4 filed by Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1057d
  SEC Form 4 filed by Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1057d
  SEC Form 4 filed by Sykes Richard

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1057d
  SEC Form 4 filed by Glover Stephen C.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1057d
  SEC Form 4 filed by Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1249d
  SEC Form 4 filed by Wood Lauren

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1249d
  SEC Form 4 filed by Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1249d
  SEC Form 4 filed by Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1249d
  SEC Form 4 filed by Hill Matthew C

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1249d
  SEC Form 4 filed by Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1284d
  SEC Form 4: Bedu-Addo Frank exercised 219,535 shares at a strike of $6.57 and covered exercise/tax liability with 175,184 shares, increasing direct ownership by 7% to 690,866 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1440d
  SEC Form 4 filed by Glover Steve C

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1440d
  SEC Form 4 filed by Iliev Ilian

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1440d
  SEC Form 4 filed by Brawley Otis W

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1440d
  SEC Form 4 filed by Freitag Gregory Gene

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1440d
  SEC Form 4 filed by Ali-Jackson Kamil

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1440d
  SEC Form 4 filed by Sykes Richard

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1466d
  SEC Form 4 filed by Brown Spencer D.

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1466d
  SEC Form 3 filed by new insider Brown Spencer D.

  3 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1600d
  SEC Form 4 filed by Bedu-Addo Frank

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1600d
  SEC Form 4 filed by Wood Lauren

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1600d
  SEC Form 4 filed by Conn Gregory

  4 - PDS Biotechnology Corp (0001472091) (Issuer)
• 1637d
  SEC Form 4: Hill Matthew C bought $27,860 worth of shares (3,100 units at $8.99), increasing direct ownership by 297% to 3,875 units

  4 - PDS Biotechnology Corp (0001472091) (Issuer)